查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1373935

生物工程蛋白藥物市場，按藥物類型、疾病、技術、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Bioengineered Protein Drugs Market, by Drugs Type, by Diseases, by Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 289 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年生物工程蛋白藥物市場規模為354,10022萬美元，2023年至2030年複合CAGR為8.01%。

這些療法在醫學領域佔有重要地位，因為它們能夠精確地針對特定的生物過程，最大限度地減少不良反應，並有望改善患者的健康和整體福祉。

生物工程蛋白藥物市場-市場動態

複雜且難以治療的疾病的盛行率不斷上升，推動了市場需求

複雜且難以治療的疾病的日益流行大幅推動了對生物工程蛋白質藥物的需求。自體免疫疾病、癌症和罕見遺傳疾病等疾病通常需要高度針對性和個人化的治療。生物工程蛋白質療法，例如酵素替代物和單株抗體，是治療這些疾病的精確而有效的解決方案的例證。

此外，生物技術和基因工程的進步使得更有效地生產這些療法成為可能，降低了生產成本並提高了可近性。因此，對生物工程蛋白質療法的需求不斷成長，因為它們具有改善患者治療效果和生活品質的潛力，加上對疾病根本原因的深入了解和客製化治療的前景。

生物工程蛋白質藥物市場 - 關鍵見解

根據研究分析師提供的分析，預計2023年至2030年的預測期內，全球生物工程蛋白藥物市場的年成長率約為8.01%。

生物工程蛋白藥物行業有望實現顯著成長，這主要是由複雜且難以治療的疾病的日益流行所推動的。

從藥物類型細分來看，2022年治療酵素將成為市場的主導類別。

在疾病細分方面，糖尿病在2022年成為主導細分市場。

從技術細分來看，2022年醫藥領域處於領先地位。

最後，就地區而言，北美地區脫穎而出，成為2022年的主要收入來源。

生物工程蛋白藥物市場-細分分析：

全球生物工程蛋白藥物市場根據藥物類型、疾病、技術和地區進行細分。

就藥物類型而言，市場涵蓋一系列類別，包括胜肽激素、重組蛋白藥物、治療酵素、疫苗、細胞激素、單株抗體、胜肽抗生素、替代蛋白等。值得注意的是，由於治療酶在治療各種醫療狀況方面的多功能性及其在個人化醫療中的潛在適用性，預計將引領生物工程蛋白藥物產業。

生物工程蛋白藥物市場-地理洞察

該市場橫跨多個地理區域，包括北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據對市場做出貢獻的國家進一步細分。

預計北美將主導市場，這主要是由於生物工程蛋白質治療領域的重大技術進步和廣泛的研究和開發努力，這有助於其在行業中的領導地位。

生物工程蛋白藥物市場-競爭格局：

公司透過多種管道分銷產品，包括公司網站、電子商務平台、零售店、分銷合作夥伴和直接面對消費者的銷售。這些產品製造商在多個維度中競爭，包括定價、產品性能、製造能力、分銷管道、品牌聲譽和產品可用性。

為了增強市場佔有率並擴大市場佔有率，企業採用各種策略。這些策略包括推出新產品、擴大分銷網路、投資研發以及參與併購。例如，2022年 4月，Satellite Bio 推出了一種創新的組織工程方法。該公司致力於再生醫學、合成生物學、細胞生物學、細胞治療和組織工程。

目錄

第1章 生物工程蛋白藥物市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依藥物類型分類的生物工程蛋白藥物市場摘錄
    • 依疾病分類的生物工程蛋白質藥物市場摘錄
    • 依技術分類的生物工程蛋白藥物市場摘錄
    • 依國家分類的生物工程蛋白藥物市場摘錄
    • 依地區分類的生物工程蛋白藥物市場摘錄
  • 競爭洞察

第3章 生物工程蛋白質藥物主要市場趨勢

  • 生物工程蛋白藥物市場促進因素
    • 市場促進因素的影響分析
  • 生物工程蛋白藥物市場限制
    • 市場限制影響分析
  • 生物工程蛋白質藥物的市場機會
  • 生物工程蛋白藥物市場未來趨勢

第4章 生物工程蛋白藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 生物工程蛋白藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 生物工程蛋白藥物市場格局

  • 2022年生物工程蛋白藥物市場佔有率分析
  • 細分資料：按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 生物工程蛋白質藥物市場 - 依藥物類型

  • 概述
    • 依藥物類型分類的細分市場佔有率分析
    • 胜肽激素
    • 重組蛋白藥物
    • 治療酵素
    • 疫苗
    • 細胞因子
    • 單株抗體
    • 胜肽類抗生素
    • 替代蛋白
    • 其他

第8章 生物工程蛋白質藥物市場 - 依疾病分類

  • 概述
    • 依疾病分類的細分市場佔有率分析
    • 癌症
    • 糖尿病
    • 血液疾病
    • 皮膚病
    • 神經退化性疾病
    • 心臟疾病
    • 傳染性疾病
    • 呼吸疾病
    • 其他

第9章 生物工程蛋白質藥物市場 - 依技術分類

  • 概述
    • 依技術分類的細分市場佔有率分析
    • 生物反應器和微生物細胞發酵
    • 分餾
    • 基因改造生物
    • 基因工程
    • 網域嫁接
    • 其他

第10章 生物工程蛋白質藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美生物工程蛋白藥物主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依藥物類型）
    • 北美市場規模與預測（依疾病）
    • 北美市場規模和預測（依技術）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲生物工程蛋白藥物主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（依藥物類型）
    • 歐洲市場規模與預測（依疾病）
    • 歐洲市場規模與預測（依技術）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區生物工程蛋白藥物主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模和預測（依藥物類型）
    • 亞太地區市場規模與預測（依疾病）
    • 亞太地區市場規模與預測（依技術）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物工程蛋白藥物主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依藥物類型）
    • 拉丁美洲市場規模與預測（依疾病）
    • 拉丁美洲市場規模與預測（依技術）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲生物工程蛋白質藥物主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依藥物類型）
    • 中東和非洲市場規模及預測（依疾病）
    • 中東和非洲市場規模及預測（依技術）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章 主要供應商分析 - 生物工程蛋白藥物產業

  • 競爭儀表板
  • 公司簡介
    • Vertex Pharmaceuticals
    • Sanofi
    • Regeneron Pharmaceuticals
    • Pfizer
    • Novo Nordisk
    • Merck & Co.
    • Johnson & Johnson（Janssen Pharmaceuticals）
    • Gilead Sciences
    • Genentech（Roche）
    • Eli Lilly and Company
    • Bristol-Myers Squibb
    • Biogen
    • AstraZeneca
    • Amgen
    • AbbVie

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1810

REPORT HIGHLIGHT

Bioengineered Protein Drugs Market size was valued at USD 3,54,100.22 Million in 2022, expanding at a CAGR of 8.01% from 2023 to 2030.

Bioengineered protein therapeutics encompass medically valuable compounds generated through genetic engineering methodologies, often leveraging living organisms such as mammalian cells or bacteria to produce proteins with distinct therapeutic attributes. These medications emulate or enhance the functions of naturally occurring proteins within the body and are employed for the treatment of various medical conditions, including diabetes, cancer, and autoimmune disorders.

These therapeutics hold a significant place in the field of medicine due to their precision in targeting specific biological processes, their potential to minimize adverse effects, and their promise in improving the health and overall well-being of patients.

Bioengineered Protein Drugs Market- Market Dynamics

Increasing prevalence of complex and challenging-to-treat diseases to propel market demand

The demand for medications derived from bioengineered proteins is significantly propelled by the increasing prevalence of complex and challenging-to-treat diseases. Conditions such as autoimmune disorders, cancer, and rare genetic ailments often necessitate highly targeted and personalized treatments. Bioengineered protein therapeutics, such as enzyme replacements and monoclonal antibodies, exemplify precise and potent solutions for managing these disorders.

Furthermore, advancements in biotechnology and genetic engineering have made it possible to produce these therapeutics more efficiently, leading to reduced production costs and improved accessibility. Consequently, there is a growing demand for bioengineered protein therapeutics owing to their potential to enhance patient outcomes and quality of life, coupled with an enhanced understanding of the underlying causes of diseases and the promise of tailored treatments.

Bioengineered Protein Drugs Market- Key Insights

According to the analysis provided by our research analyst, the global market for Bioengineered Protein Drugs is expected to witness an annual growth rate of approximately 8.01% over the forecast period spanning from 2023 to 2030.

The Bioengineered Protein Drugs industry is poised for significant growth, primarily driven by the increasing prevalence of complex and challenging-to-treat diseases.

In terms of drug type segmentation, the year 2022 saw Therapeutic enzymes as the leading category in the market.

Regarding disease segmentation, Diabetes emerged as the dominant segment in 2022.

In terms of technology segmentation, Pharming was the leading category in 2022.

Finally, with respect to regions, North America stood out as the leading revenue generator in 2022.

Bioengineered Protein Drugs Market- Segmentation Analysis:

The Global Bioengineered Protein Drugs Market is segmented based on Drug Type, Disease, Technology, and Region.

In terms of Drug Type, the market encompasses a range of categories including Peptide hormones, Recombinant protein drugs, Therapeutic enzymes, Vaccines, Cytokines, Monoclonal antibodies, Peptide antibiotics, Replacement proteins, and Others. Notably, therapeutic enzymes are expected to lead the bioengineered protein drug industry due to their versatility in treating various medical conditions and their potential applicability in personalized medicine.

Bioengineered Protein Drugs Market- Geographical Insights

This market spans across various geographical regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented according to the countries contributing to the market.

North America is anticipated to dominate the market, primarily due to significant technological advancements and extensive research and development efforts in the field of bioengineered protein therapeutics, which have contributed to its leadership position in the industry.

Bioengineered Protein Drugs Market- Competitive Landscape:

Companies distribute their products through a variety of channels, which encompass corporate websites, e-commerce platforms, retail outlets, distribution partners, and direct-to-consumer sales. These product manufacturers engage in competition across several dimensions, including pricing, product performance, manufacturing capabilities, distribution channels, brand reputation, and product availability.

To enhance their market presence and expand their market share, businesses employ various strategies. These strategies encompass launching new products, expanding their distribution networks, investing in research and development, and engaging in mergers and acquisitions. As an example, in April 2022, Satellite Bio introduced an innovative approach to tissue engineering. This company specializes in regenerative medicine, synthetic biology, cell biology, cell therapy, and tissue engineering.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET KEY PLAYERS

  • Vertex Pharmaceuticals
  • Sanofi
  • Regeneron Pharmaceuticals
  • Pfizer
  • Novo Nordisk
  • Merck & Co.
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Gilead Sciences
  • Genentech (Roche)
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Biogen
  • AstraZeneca
  • Amgen
  • AbbVie

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DRUG TYPE

  • Peptide hormones
  • Recombinant protein drugs
  • Therapeutic enzymes
  • Vaccines
  • Cytokines
  • Monoclonal antibodies
  • Peptide antibiotics
  • Replacement proteins
  • Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DISEASES

  • Cancer
  • Diabetes
  • Blood disorders
  • Skin diseases
  • Neurodegenerative diseases
  • Heart diseases
  • Infectious diseases
  • Respiratory diseases
  • Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY TECHNOLOGY

  • Bioreactors and Microbial Cell Fermentation
  • Fractionation
  • Genetically Modified Organisms
  • Genetic Engineering
  • Pharming
  • Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioengineered Protein Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioengineered Protein Drugs Market Snippet by Drug Type
    • 2.1.2. Bioengineered Protein Drugs Market Snippet by Diseases
    • 2.1.3. Bioengineered Protein Drugs Market Snippet by Technology
    • 2.1.4. Bioengineered Protein Drugs Market Snippet by Country
    • 2.1.5. Bioengineered Protein Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioengineered Protein Drugs Key Market Trends

  • 3.1. Bioengineered Protein Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioengineered Protein Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioengineered Protein Drugs Market Opportunities
  • 3.4. Bioengineered Protein Drugs Market Future Trends

4. Bioengineered Protein Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioengineered Protein Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bioengineered Protein Drugs Market Landscape

  • 6.1. Bioengineered Protein Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioengineered Protein Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Peptide hormones
    • 7.1.3. Recombinant protein drugs
    • 7.1.4. Therapeutic enzymes
    • 7.1.5. Vaccines
    • 7.1.6. Cytokines
    • 7.1.7. Monoclonal antibodies
    • 7.1.8. Peptide antibiotics
    • 7.1.9. Replacement proteins
    • 7.1.10. Others

8. Bioengineered Protein Drugs Market - By Diseases

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
    • 8.1.2. Cancer
    • 8.1.3. Diabetes
    • 8.1.4. Blood disorders
    • 8.1.5. Skin diseases
    • 8.1.6. Neurodegenerative diseases
    • 8.1.7. Heart diseases
    • 8.1.8. Infectious diseases
    • 8.1.9. Respiratory diseases
    • 8.1.10. Others

9. Bioengineered Protein Drugs Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 9.1.2. Bioreactors and Microbial Cell Fermentation
    • 9.1.3. Fractionation
    • 9.1.4. Genetically Modified Organisms
    • 9.1.5. Genetic Engineering
    • 9.1.6. Pharming
    • 9.1.7. Others

10. Bioengineered Protein Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bioengineered Protein Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bioengineered Protein Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bioengineered Protein Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bioengineered Protein Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bioengineered Protein Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bioengineered Protein Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Vertex Pharmaceuticals
    • 11.2.2. Sanofi
    • 11.2.3. Regeneron Pharmaceuticals
    • 11.2.4. Pfizer
    • 11.2.5. Novo Nordisk
    • 11.2.6. Merck & Co.
    • 11.2.7. Johnson & Johnson (Janssen Pharmaceuticals)
    • 11.2.8. Gilead Sciences
    • 11.2.9. Genentech (Roche)
    • 11.2.10. Eli Lilly and Company
    • 11.2.11. Bristol-Myers Squibb
    • 11.2.12. Biogen
    • 11.2.13. AstraZeneca
    • 11.2.14. Amgen
    • 11.2.15. AbbVie

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bioengineered Protein Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Bioengineered Protein Drugs Market, by Drug Type 2018-2030 (USD Million)
  • TABLE Bioengineered Protein Drugs Market: Diseases Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diseases
  • TABLE Global Bioengineered Protein Drugs Market, by Diseases 2018-2030 (USD Million)
  • TABLE Bioengineered Protein Drugs Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Bioengineered Protein Drugs Market, by Technology 2018-2030 (USD Million)
  • TABLE Bioengineered Protein Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bioengineered Protein Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE North America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Europe Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Latin America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)

List of Figures

  • FIGURE Bioengineered Protein Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022 & 2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Diseases segment market share analysis, 2022 & 2030
  • FIGURE Diseases segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Europe Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Latin America Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Bioengineered Protein Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE Germany Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE India Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE Brazil Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bioengineered Protein Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)